Effect of cabergoline on thyroid function in hyperprolactinaemia

Simple item page
dc.contributor.authorKeogh, M.
dc.contributor.authorWittert, G.
dc.date.issued2002
dc.descriptionThe definitive version is available at www.blackwell-synergy.com
dc.description.statementofresponsibilityM.A. Keogh and G.A. Wittert
dc.description.urihttp://www.ncbi.nlm.nih.gov/pubmed/12390347
dc.identifier.citationClinical Endocrinology, 2002; 57(5):699-699
dc.identifier.doi10.1046/j.1365-2265.2002.16351.x
dc.identifier.issn0300-0664
dc.identifier.issn1365-2265
dc.identifier.orcidWittert, G. [0000-0001-6818-6065]
dc.identifier.urihttp://hdl.handle.net/2440/33117
dc.language.isoen
dc.publisherBlackwell Science Ltd
dc.source.urihttps://doi.org/10.1046/j.1365-2265.2002.16351.x
dc.titleEffect of cabergoline on thyroid function in hyperprolactinaemia
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications